Spryson
Toronto, Ontario, CanadaSee on the mapFounded 2019
Spryson develops eye-tracking and vestibular assessment systems that help clinicians and researchers objectively measure brain, balance, and eye-movement function. Its FDA-cleared products and software are used by more than 350 clinical and research organizations.
- RaisedTotal raised
- $1.2M
- Investor
- 1
- Founded
- 2019
- Employees
- 11–50
reccy insights
Spryson's available company milestones center on its diagnostic platform rather than a dated sequence of announcements. The company develops eye-tracking and vestibular assessment systems for measuring brain, balance, and eye-movement function. Its product portfolio combines goggles, a motorized rotational chair, and clinical software, and its technology has five FDA 510(k) clearances. Spryson reports more than 400,000 tests conducted across over 350 clinical and research organizations, indicating use beyond a single specialty or research setting. The company also describes normative comparisons and longitudinal tracking to support interpretation of results over time. A dated financial milestone is a $753,267 grant recorded on Apr 1, 2019, with HHS named as lead investor. Together, these facts point to a focus on objective measurement and repeatability in clinical and research workflows.
Written by reccy's AI from company sites, press and funding records · updated Nov 2026
What makes Spryson distinct
- 01Combines eye-tracking and vestibular assessment across goggles, a rotational chair, and clinical software.
- 02Has five FDA 510(k) clearances and supports objective, repeatable assessment.
- 03Reports more than 400,000 tests across over 350 clinical and research organizations.
- 04Provides normative reference comparisons and longitudinal tracking to help interpret results over time.
- 05Serves clinical and research settings including neurology, vestibular care, concussion assessment, rehabilitation, and clinical trials.
Technology & products4
- DX200
Eye-tracking goggles with oculomotor, vestibular, reaction-time, and cognitive testing.
- NOTC Pro+
Motorized rotational chair for vestibular assessment.
- Falcon vHIT
Video goggles for head-impulse and positional testing.
+ 1 more: Clinical software
Funding
- Grant (prize money)Apr 2019$753KLed by HHS
Investors1
About Spryson
- Products
- DX200, NOTC Pro+, Falcon vHIT, Clinical software
- Leadership
- Claudia DovaliPrateek DwivediRob Adelson
- Focus areas
- Medical devices, digital health, eye tracking, vestibular assessment, clinical diagnostics, neurology, clinical research, healthcare technology
- Headquarters
- Toronto, Ontario, Canada
- Founded
- 2019
- Employees
- 11–50